Cargando…
A de novo GRIN1 Variant Associated With Myoclonus and Developmental Delay: From Molecular Mechanism to Rescue Pharmacology
N-Methyl-D-aspartate receptors (NMDARs) are highly expressed in brain and play important roles in neurodevelopment and various neuropathologic conditions. Here, we describe a new phenotype in an individual associated with a novel de novo deleterious variant in GRIN1 (c.1595C>A, p.Pro532His). The...
Autores principales: | Zhang, Jin, Tang, Weiting, Bhatia, Nidhi K., Xu, Yuchen, Paudyal, Nabina, Liu, Ding, Kim, Sukhan, Song, Rui, XiangWei, Wenshu, Shaulsky, Gil, Myers, Scott J., Dobyns, William, Jayaraman, Vasanthi, Traynelis, Stephen F., Yuan, Hongjie, Bozarth, Xiuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369916/ https://www.ncbi.nlm.nih.gov/pubmed/34413877 http://dx.doi.org/10.3389/fgene.2021.694312 |
Ejemplares similares
-
A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia
por: Gao, Kai, et al.
Publicado: (2017) -
Distinct roles of
GRIN2A and
GRIN2B variants in neurological conditions
por: Myers, Scott J, et al.
Publicado: (2019) -
Human GRIN2B variants in neurodevelopmental disorders
por: Hu, Chun, et al.
Publicado: (2016) -
Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-function
por: Myers, Scott J, et al.
Publicado: (2023) -
Recurrent seizure‐related GRIN1 variant: Molecular mechanism and targeted therapy
por: Xu, Yuchen, et al.
Publicado: (2021)